Vor Biopharma (VOR) shares sold for $14.5 million by Ra Capital

Ra Capital sold its shares in Vor Biopharma (VOR) for $14.5 million. This transaction indicates a significant movement of shares in the biopharma sector. The sale may influence market perception of VOR’s future potential and could affect trading volume. Investors may look for further developments in VOR's performance following this divestment.